AR collaborates with ERα in aromatase inhibitor-resistant breast cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer
Authors
Keywords
Androgen receptor, Estrogen receptor, Breast cancer, Hormone resistance, Aromatase inhibitor
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 147, Issue 3, Pages 473-485
Publisher
Springer Nature
Online
2014-09-01
DOI
10.1007/s10549-014-3082-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abstract 2397: Correlation between biomarker status and response to EGFR inhibition in triple-negative breast cancer (TNBC): findings from a Phase II trial.
- (2014) Denise Yardley et al. CANCER RESEARCH
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Molecular characterization of anastrozole resistance in breast cancer: Pivotal role of the Akt/mTOR pathway in the emergence ofde novoor acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitor
- (2013) Paul Vilquin et al. INTERNATIONAL JOURNAL OF CANCER
- Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer
- (2013) Javier Guerrero et al. PROSTATE
- Ack1-mediated Androgen Receptor Phosphorylation Modulates Radiation Resistance in Castration-resistant Prostate Cancer
- (2012) Kiran Mahajan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Minireview: The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?
- (2012) T. E. Hickey et al. MOLECULAR ENDOCRINOLOGY
- Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy
- (2011) Lisa Gallicchio et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
- (2011) Min Ni et al. CANCER CELL
- Dicer-Mediated Upregulation of BCRP Confers Tamoxifen Resistance in Human Breast Cancer Cells
- (2011) J. Selever et al. CLINICAL CANCER RESEARCH
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Loss of Rho GDIα and Resistance to Tamoxifen via Effects on Estrogen Receptor α
- (2011) Ines Barone et al. JNCI-Journal of the National Cancer Institute
- Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression
- (2011) C Giordano et al. ONCOGENE
- Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer
- (2011) A Urbanucci et al. ONCOGENE
- Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure
- (2011) Alfonso Urbanucci et al. PROSTATE
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo
- (2010) Craig Cherrin et al. CANCER BIOLOGY & THERAPY
- Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers
- (2010) Donata Micello et al. VIRCHOWS ARCHIV
- Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells
- (2009) Francesca De Amicis et al. BREAST CANCER RESEARCH AND TREATMENT
- Expression of the K303R Estrogen Receptor- Breast Cancer Mutation Induces Resistance to an Aromatase Inhibitor via Addiction to the PI3K/Akt Kinase Pathway
- (2009) I. Barone et al. CANCER RESEARCH
- Androgen Receptor Inhibits Estrogen Receptor- Activity and Is Prognostic in Breast Cancer
- (2009) A. A. Peters et al. CANCER RESEARCH
- Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells
- (2009) Robert X.-D. Song et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
- (2008) S. Massarweh et al. CANCER RESEARCH
- GEMS (Gene Expression Metasignatures), a Web Resource for Querying Meta-analysis of Expression Microarray Datasets: 17 -Estradiol in MCF-7 Cells
- (2008) S. A. Ochsner et al. CANCER RESEARCH
- Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells
- (2008) Richard J. Santen et al. STEROIDS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search